Form C/A — iMetabolic Biopharma Corporation
0001665160-23-000746 · filed Apr 24, 2023
· via StartEngine Capital, LLC
Offering
- Target
- $10,000
- Maximum
- $1,230,000
- Security type
- Other
- Price per security
- —
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 1957114
- Entity
- Corporation
- Jurisdiction
- NV
- Address
- 275 N Gateway Dr, Suite 104
Phoenix, AZ 85034 - Phone
- —
Most recent fiscal year financials
- Total assets
- $4,601
- Cash
- —
- Short-term debt
- —
- Long-term debt
- $161,025
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-94,513
View the original filing on SEC EDGAR ↗